Effect of kainic acid treatment on insulin-like growth factor-2 receptors in the IGF2-deficient adult mouse brain

Brain Research

Volumn 1131, Issue 1, 2007, Pages 77-87

  Dikkes, P ^a   Hawkes, C ^b,c   Kar, S ^b,c   Lopez, M F ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hippocampus; Insulin; Insulin like growth factor; Kainic acid; Receptor autoradiography

Indexed keywords

INSULIN; INSULIN RECEPTOR; KAINIC ACID; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE DELETION; IN VITRO STUDY; MOUSE; NEUROANATOMY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; WILD TYPE;

AGE FACTORS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; BRAIN DAMAGE, CHRONIC; CEREBELLUM; DOWN-REGULATION; DRUG RESISTANCE; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; IODINE RADIOISOTOPES; KAINIC ACID; MALE; MICE; MICE, KNOCKOUT; NEUROTOXINS; RADIOLIGAND ASSAY; RECEPTOR, IGF TYPE 2; RECEPTOR, INSULIN;

MUS;

EID: 33846030839     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.11.022     Document Type: Article

References (64)

1. Adamo M., Raizada M.K., and LeRoith D. Insulin and insulin-like growth factor receptors in the nervous system. Mol. Neurobiol. 3 (1989) 71-100
2. Aizeman Y., and De Vellis J. Brain neurones develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res. 406 (1987) 32-42
3. Baskin D.G., Wilcox B.J., Figlewicz D.P., and Dorsa D.M. Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11 (1988) 107-111
4. Beilharz E.J., Bassett N.S., Sirimanne E.S., Williams C.E., and Gluckman P.D. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol. Brain Res. 29 (1995) 81-91
5. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14 (1985) 375-403
6. Ben-Ari Y., Tremblay E., Tiche D., Ghilini G., and Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to pathology of epilepsy. Neuroscience 6 (1981) 1361-1391
7. Binoux M., Lassarre C., and Gourmelen M. Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from human cerebrospinal fluid. J. Clin. Endocrinol. Metab. 63 (1986) 1151-1155
8. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., and Baskin D.G. Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res. 444 (1988) 205-213
9. Breese C.R., D'costa A., Rollins Y.D., Adams C., Booze R.M., Sonntag W.E., and Leonard S. Expression of insulin-like growth factor-1 (IGF-1) and IGF-binding protein 2 (IGF-BP2) in the hippocampus following cytotoxic lesion of the dentate gyrus. J. Comp. Neurol. 369 (1996) 388-404
10. Carson M.J., Behringer R.R., Brinster R.L., and McMorris F.A. Insulin-like growth factor-I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10 (1993) 729-740
11. Cheng B., and Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurones against calcium-mediated hypoglycemic damage. J. Neurosci. 12 (1992) 1558-1566
12. Cheng C.M., Cohen M., Tseng V., and Bondy C.A. Endogenous IGF1 enhances cell survival in the postnatal dentate gyrus. J. Neurosci. Res. 64 (2001) 341-347
13. Czech M. Signal transmission by insulin-like growth factors. Cell 59 (1989) 235-238
14. DeChiara T.M., Efstratiadis A., and Robertson E.J. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 296 (1990) 78-80
15. D'Ercole J., Ye P., Calikoglu A.S., and Gutierrez-Ospina G. The role of insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13 (1996) 227-255
16. D'Ercole A.J., Ye P., and O'Kusky J.R. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36 (2002) 209-220
17. D'Mello S.R., Galli C., Ciotti T., and Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10989-10993
18. Doré S., Karm S., and Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4772-4777
19. Enberg G., Tham A., and Sara V.R. The influence of purified somatomedins and insulin on foetal rat brain DNA synthesis in vitro. Acta Physiol. Sand. 125 (1985) 305-308
20. Folli F., Ghidella S., Bonfanti L., Kahn C.R., and Merighi A. The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system. Mol. Neurobiol. 13 (1996) 155-183
21. Guan J., Williams C., Gunning M., Mallard E.C., and Gluckman P.D. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J. Cereb. Blood Flow Metab. 13 (1995) 609-616
22. Guan J., Williams C.E., Skinner S.J., Mallard E.C., and Gluckman P.D. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 137 (1996) 893-898
23. Guthrie K.M., Nguyen T., and Gall C.M. Insulin-like growth factor-1 mRNA is increased in deafferented hippocampus: spatiotemporal correspondence of a trophic event with axon sprouting. J. Comp. Neurol. 352 (1995) 147-160
24. Hari J., Pierce S., Morgan D., Sara V., Smith M., and Roth R. The receptor for insulin-like growth factor-II mediates an insulin-like response. EMBO J. 6 (1987) 3367-3371
25. Haselbacher G., Groscurth P., Otten U., Vedder H., Lutz U., Sonderegger P., Bulatko A., Greff N., and Humbel R. Long term cultivation of cryopreserved human brain cells in chemically defined medium. J. Neurosci. Methods 30 (1989) 121-131
26. Hirata A., Yoshida S., Inoue N., Matsumoto-Miyai K., Ninomiya A., Taniguchi M., Matsuyama T., Kato K., Iizasa H., Kataoka Y., Yoshida N., and Shiosaka S. Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice. Mol. Cell. Neurosci. 17 (2001) 600-610
27. Hopkins K.J., Wang G., and Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 864 (2000) 69-80
28. Hawkes C., and Kar S. Insulin-like growth factor-II/Mannose-6-phosphate receptor in the spinal cord and dorsal root ganglia of the adult rat. Eur. J. Neurosci. 15 (2002) 33-39
29. Hawkes C., Jhamandas J.H., Fu J., Macdonal R.G., and Kar S. Single transmembrane insulin-like growth factor-II/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway. J. Neurosci. 26 (2006) 586-596
30. Ishii D.N. Relationship of insulin-like growth factor II gene expression in muscle synaptogenesis. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2902-28988
31. Izumi Y., Pinard E., Roussel S., and Seylaz J. Insulin protects brain tissue against focal ischemia in rat. Neurosci. Lett. 144 (1992) 121-123
32. Jones J., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
33. Juarez-Mendez S., Carretero R., Martinez-Tellez R., Silva-Gomez A.B., and Flores G. Neonatal caffeine administration causes a permanent increase in the dendritic length of prefrontal cortical neurons of rats. Synapse 60 (2006) 450-455
34. 125I]insulin receptor binding sites in developing and adult rat brain. J. Comp. Neurol. 333 (1993) 375-397
35. 125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience 55 (1993) 69-80
36. Kar S., Seto D., Dore S., Hanisch U.K., and Quirion R. Insulin-like growth factors-I and II differentially regulate acetylcholine release from the rat hippocampal formation. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14054-14059
37. 125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience 80 (1997) 1041-1055
38. Knusel B., Michel P.P., Schwaber J.S., and Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin, and insulin like growth factors 1 and 2. J. Neurosci. 10 (1990) 558-570
39. Kornfeld S. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Annu. Rev. Biochem. 61 (1992) 307-330
40. Lee W.H., Clemens J.A., and Bondy C.A. Insulin-like growth factors in the response to cerebral ischemia. Mol. Cell. Neuroscie. 3 (1992) 36-43
41. Lesniak M.A., Hill J.M., Keiss W., Rojeski M., Pert C.B., and Roth J. Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 123 (1988) 2089-2099
42. Lim R., Miller J.F., Hicklin D.J., Holm A.C., and Ginsberg B.H. Mitogenic activity of glia maturation factor. Interaction with insulin and insulin-like growth factor II. Exp. Cell Res. 159 (1985) 335-343
43. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14 (1994) 3413-3425
44. Nakae J., Kido Y., and Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22 (2001) 818-883
45. Nakao N., Odin P., Lindvall O., and Brundin P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurones in culture. Exp. Neurol. 138 (1996) 144-157
46. Pollard H., Charriaut-Marlangue C., Moreau J., and Ben-Ari J. Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroscience 63 (1994) 7-18
47. Recio-Pinto E., Rechler M.M., and Ishii D.N. Effects of insulin, insulin-like growth factor II and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurones. J. Neurosci. 6 (1986) 1211-1219
48. Rosen K.M., Wentworth B.M., Rosenthal N., and Villa-Komaroff L. Specific, temporally regulated expression of the insulin-like growth factor gene during muscle cell differentiation. Endocrinology 133 (1993) 474-481
49. Russo V.C., Gluckman P.D., Feldman E.L., and Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 26 (2005) 916-943
50. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning-A Laboratory Manual. 2nd edition (1989), Cold Spring Harbor Laboratory, New York 9.31-9.57
51. Shimaski S., and Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1,-2,-3,-4,-5,-6 ). Prog. Growth Factor Res. 1 (1991) 243-266
52. Soares M.B., Ishii D.N., and Efstratiadis A. Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA. Nucleic Acids Res. 13 (1985) 1119-1134
53. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42 (1994) 1-32
54. Tally M., Li C.H., and Hall K. IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochem. Biophys. Res. Commun. 148 (1987) 811-816
55. Tooyama I., Bellier J.P., Park M., Minnasch P., Uemura S., Hisano T., Iwami M., Aimi Y., Yasuhara O., and Kimura H. Morphologic study of neuronal death, glial activation, and progenitor cell division in the hippocampus of rat models of epilepsy. Epilepsia 43 Suppl. 9 (2002) 39-43
56. Unger J.W., Livingston J.N., and Moss A.M. Insulin receptors in the central nervous system: localization, signaling mechanisms and functional aspects. Prog. Neurobiol. 36 (1991) 343-362
57. Walter H.J., Berry D., Hill D.J., Cwyfan-Hughes S., Holly J.M.P., and Logan A. Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: possible roles of IGF binding proteins (IGFBPs) in the mediation of IGF-II activity. Endocrinology 140 (1999) 520-531
58. Weiss S., Cataltepe O., and Cole A.J. Anatomical studies of DNA fragmentation in rat brain after systemic kainic acid administration. Neuroscience 7 (1996) 541-551
59. Werther G.A., Hogg A., Oldfield B.J., McKinley M.J., Figdor R., and Mendelsohn F.A.O. Localization and characterization of IGF-I receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry: a distinct distribution from insulin receptors. J. Neuroendocrinol. 1 (1990) 369-377
60. Westerlain C.G., Fujikawa D.G., Penix L., and Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 34 (1993) S37-S53
61. Ye P., Carson J., and D'Ercole J.A. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15 (1995) 7344-7356
62. Ye P., Li L., Richards R.G., DiAugustine R.P., and D'Ercole J.A. Myelination is altered in insulin-like growth factor-I null mutant mice. J. Neurosci. 22 (2002) 6041-6051
63. Young D., and Dragunow M. Neuronal injury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp. Neurol. 133 (1995) 125-137
64. Zona C., Ciotti M.T., and Calissano P. Human recombinant IGF-I induces the functional expression of AMPA/kainate receptors in cerebellar granule cells. Neurosci. Lett. 186 (1995) 75-78